Local radiation therapy (RT) improves overall survival (OS) by 32% in patients diagnosed with metastatic prostate cancer who have a low metastatic disease burden, according to a study presented at the 2018 annual meeting of the European Society for Medical Oncology (abstract LBA5_PR).
The results also showed the modified regimen improved failure-free survival (FFS) by 24% for all men who received local RT along with the standard of care, androgen deprivation therapy (ADT).
“For the first